RNU6-1 and glioblastoma: RNU6-1 identified in serum exosomes could effectively distinguish GBM patients from healthy individuals.The elevated levels of RNU6-1 in GBM patients’ exosomes suggest its potential as a non-invasive diagnostic biomarker.